Biosimilar Bevacizumab Market - Anti-Angiogenic Cancer Therapy and...

добавлена новая статья Health

2026-07-08 09:26:17 -

Market Overview The global Biosimilar Bevacizumab Market is experiencing explosive growth driven by anti-angiogenic cancer therapy demand, cost-effective oncology emphasis, and biosimilar regulatory pathway maturation. The global biosimilar bevacizumab market is projected to exceed USD 30 billion through 2030, fueled by colorectal cancer treatment expansion, non-small cell lung cancer adoption,...

0 Комментарии 0 Поделились 5 Просмотры 0 предпросмотр